Systematic review of Farnesoid X Receptor (FXR) as a therapeutic target in diabetic cardiomyopathy and cardiometabolic diseases. // American Heart Journal Plus: Cardiology Research and Practice. – URL: https://www.sciencedirect.com/science/article/pii/S2666602226002880?dgcid=rss_sd_all
Systematic review of Farnesoid X Receptor (FXR) as a therapeutic target in diabetic cardiomyopathy and cardiometabolic diseases. American Heart Journal Plus: Cardiology Research and Practice. https://www.sciencedirect.com/science/article/pii/S2666602226002880?dgcid=rss_sd_all
“Systematic review of Farnesoid X Receptor (FXR) as a therapeutic target in diabetic cardiomyopathy and cardiometabolic diseases.” American Heart Journal Plus: Cardiology Research and Practice.
@article{article34398,
title = {Systematic review of Farnesoid X Receptor (FXR) as a therapeutic target in diabetic cardiomyopathy and cardiometabolic diseases},
journal = {American Heart Journal Plus: Cardiology Research and Practice},
url = {https://www.sciencedirect.com/science/article/pii/S2666602226002880?dgcid=rss_sd_all}
}